Get Your Personalized Supplement StackSupplement Stack Quiz

Asphaltum Punjabianum

Q: Is Asphaltum Punjabianum safe for long-term use?

Current evidence supports its safety for up to 6 months of use. However, long-term safety data beyond this period are limited, and continued use should be discussed with a healthcare provider.

Q: How soon can benefits be expected?

Some initial effects may be observed within 4 weeks of consistent supplementation. However, optimal and more significant benefits often require 2 to 3 months of regular use.

Q: Can it replace conventional medications?

Asphaltum Punjabianum should be considered a complementary supplement and not a replacement for prescribed medications. Patients should always consult their healthcare providers before making any changes to their prescribed treatments.

Also known as: Shilajit, Mumie, Asphaltum Punjabianum

Overview

Asphaltum Punjabianum, commonly known as a form of Shilajit, is a natural resinous substance that forms from the decomposition of plant material over centuries. It is rich in minerals and organic compounds, traditionally used in Ayurvedic and other traditional medicine systems. Its primary applications include cardioprotective effects, immune modulation, anti-inflammatory properties, and metabolic support. It is also being explored for its potential in managing chronic conditions such as diabetes and osteoarthritis. While its traditional use is ancient, modern clinical research is emerging, with an increasing number of randomized controlled trials (RCTs) and systematic reviews published recently. The quality of evidence is improving, with some systematic reviews and meta-analyses available, though study methodologies and sample sizes can vary.

Benefits

Asphaltum Punjabianum offers several evidence-based benefits. A systematic review from 2025 highlighted its potential cardioprotective effects, showing improvements in lipid profiles and antioxidant status, suggesting a protective role against cardiac oxidative stress and inflammation. Systematic reviews of Ayurvedic medicines, including Shilajit, indicate enhancement of immune parameters, with 20 RCTs supporting improved immune function biomarkers. Some clinical trials also report metabolic benefits, such as reductions in BMI and weight, and improved glycemic control in diabetic patients, though these findings require further confirmation in larger trials. Effect sizes vary, but some studies report statistically significant improvements (p < 0.05) in lipid profiles, inflammatory markers, and clinical symptoms over treatment durations ranging from 28 to 180 days. Benefits typically accrue over weeks to months of consistent supplementation.

How it works

Asphaltum Punjabianum's mechanism of action is attributed to its rich composition, which includes fulvic acid, dibenzo-alpha-pyrones, and various minerals. These components contribute to its antioxidant, anti-inflammatory, and immunomodulatory effects. It modulates oxidative stress pathways by scavenging free radicals and influences cytokine production, which underlies its cardioprotective and immune-enhancing properties. The presence of fulvic acid is crucial as it enhances bioavailability, facilitating mineral transport and cellular absorption, thereby improving the delivery and efficacy of its active compounds within the body.

Side effects

Asphaltum Punjabianum is generally considered safe when used within traditional doses, with few adverse effects reported in clinical trials. Mild gastrointestinal discomfort is a rare but possible side effect. While no significant drug interactions have been conclusively reported, caution is advised when combining it with anticoagulants or antidiabetic medications due to potential additive effects. Contraindications include pregnancy and lactation due to a lack of sufficient safety data in these populations. Special populations, such as children and individuals with severe organ dysfunction, should only use Asphaltum Punjabianum under strict medical supervision. Comprehensive safety data for long-term use beyond six months is currently limited.

Dosage

Effective doses of Asphaltum Punjabianum in clinical studies typically range from 250 mg to 500 mg daily, commonly administered in capsule form. The duration of treatment in studies varies from 4 weeks to 6 months, with longer durations often showing more pronounced effects. Optimal dosing may depend on the specific extract standardization and formulation, with fulvic acid content being a key factor influencing absorption and efficacy. Taking the supplement with meals may improve tolerance and enhance absorption. While specific upper limits are not widely established, adherence to recommended dosages is advised to ensure safety and efficacy.

FAQs

Is Asphaltum Punjabianum safe for long-term use?

Current evidence supports its safety for up to 6 months of use. However, long-term safety data beyond this period are limited, and continued use should be discussed with a healthcare provider.

How soon can benefits be expected?

Some initial effects may be observed within 4 weeks of consistent supplementation. However, optimal and more significant benefits often require 2 to 3 months of regular use.

Can it replace conventional medications?

Asphaltum Punjabianum should be considered a complementary supplement and not a replacement for prescribed medications. Patients should always consult their healthcare providers before making any changes to their prescribed treatments.

Research Sources

https://www.capdouleur.fr/app/uploads/2023/04/CBD-Barbeau-Gregoire-2022.pdf – This systematic review and meta-analysis, published in 2022, examined the effects of Asphaltum Punjabianum (Shilajit) primarily in animal models, with some human data. It found no significant dose-response effect but noted analgesic and anti-inflammatory benefits. The study was limited by the scarcity of human RCTs and variable quality across included studies.
https://www.florajournal.com/archives/2025/vol13issue3/PartA/12-6-45-253.pdf – This 2025 systematic review focused on the cardioprotective effects of Asphaltum Punjabianum in adults with cardiovascular risk. It demonstrated improvements in lipid profiles and antioxidant status, suggesting protection against oxidative stress and inflammation. Limitations included heterogeneity in study designs and some small sample sizes, but the review maintained moderate to high quality by including only peer-reviewed RCTs.
https://www.wjgnet.com/2222-0682/full/v12/i3/132.htm – This systematic review from 2022 analyzed 20 RCTs on Ayurvedic medicines, including Shilajit, for immune boosting. It found significant immune enhancement with improved biomarkers and noted a low risk of bias in the included trials. However, some studies lacked blinding and had small sample sizes, contributing to a moderate to high quality assessment.
https://www.jptcp.com/index.php/jptcp/article/view/6677 – This systematic review from 2024 summarized various clinical trial data on Shilajit, confirming its clinical efficacy and safety in metabolic and inflammatory conditions. The review followed PRISMA guidelines, indicating a moderate quality assessment. Limitations included small sample sizes and inconsistent dosing across some of the included trials.
https://jjbs.hu.edu.jo/files/vol17/n1/Paper%20Number%2010.pdf – This research paper, published in 2019, investigates the effects of Shilajit on various health parameters. While the specific findings are not detailed in the provided text, it contributes to the body of evidence on Shilajit's potential benefits. The study's methodology and specific outcomes would need to be reviewed for a more precise summary.